GlycoMimetics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.18 |
Market Cap |
$516.88 M |
Shares Outstanding |
43.18 M |
Public Float |
33.48 M |
Address |
9708 Medical Center Drive Rockville Maryland 20850 United States |
Employees | - |
Website | http://www.glycomimetics.com |
Updated | 07/08/2019 |
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K. |